Schizophrenia Clinical Trial
Official title:
Effects of Transcranial Direct Current Stimulation (tDCS) on Motor Function in Schizophrenia Patients and Individuals at Risk for Psychotic Onset
The purposes of this research are to investigate (1) if schizophrenia patients and at-risk individuals present bradykinesia and dyskinesia and (2) if tDCS improves motor performance in schizophrenia patients and at-risk individuals. The first hypothesis is that both schizophrenia patients and at-risk individuals show bradykinesia and dyskinesia, and the motor symptoms are more severe in the former than the latter. The second hypothesis is that tDCS improves motor performance in schizophrenia patients and at-risk cases.
Status | Recruiting |
Enrollment | 120 |
Est. completion date | December 31, 2023 |
Est. primary completion date | December 31, 2023 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 12 Years to 65 Years |
Eligibility | Inclusion Criteria for schizophrenia patients: - a diagnosis of schizophrenia without other psychiatric diseases - having stable psychotic symptoms - a score of 22 or above in Hong Kong version Montreal Cognitive Assessment - having no neurological diseases and no medical conditions that affect motor performance No Exclusion Criteria. Inclusion Criteria for at-risk individuals: - a score of nine or above in the Chinese version of the 16-item Prodromal Questionnaire (CPQ-16) - a score of 22 or above in Hong Kong version Montreal Cognitive Assessment - having no diagnosis of psychiatric diseases - having no neurological diseases and no medical conditions that affect motor performance No Exclusion Criteria. Inclusion Criteria for healthy controls: - a score less than nine in CPQ-16 - a score of 22 or above in Hong Kong version Montreal Cognitive Assessment - having no diagnosis of psychiatric diseases - having no neurological diseases and no medical conditions that affect motor performance. No Exclusion Criteria. |
Country | Name | City | State |
---|---|---|---|
Hong Kong | Hong Kong Polytechnic University | Kowloon |
Lead Sponsor | Collaborator |
---|---|
Dr WANG Shumei |
Hong Kong,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Motion analysis by using an eight-camera motion capture system (VICON; Oxford Metrics Group, Oxford, UK) | normalized movement time (representing severity of parkinsonism). Unit: second/mm | Within one week right before the 1st session of tDCS | |
Primary | Motion analysis by using an eight-camera motion capture system (VICON; Oxford Metrics Group, Oxford, UK) | normalized movement time (representing severity of parkinsonism). Unit: second/mm | Within one week right after the 8th (last) session of tDCS | |
Primary | Motion analysis by using an eight-camera motion capture system (VICON; Oxford Metrics Group, Oxford, UK) | normalized number of movement units (representing severity of dyskinesia). Unit: units/mm | Within one week right before the 1st session of tDCS | |
Primary | Motion analysis by using an eight-camera motion capture system (VICON; Oxford Metrics Group, Oxford, UK) | normalized number of movement units (representing severity of dyskinesia). Unit: units/mm | Within one week right after the 8th (last) session of tDCS |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05039489 -
A Study on the Brain Mechanism of cTBS in Improving Medication-resistant Auditory Hallucinations in Schizophrenia
|
N/A | |
Completed |
NCT05111548 -
Brain Stimulation and Cognitive Training - Efficacy
|
N/A | |
Completed |
NCT05321602 -
Study to Evaluate the PK Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective Disorder
|
Phase 1 | |
Completed |
NCT04503954 -
Efficacy of Chronic Disease Self-management Program in People With Schizophrenia
|
N/A | |
Completed |
NCT02831231 -
Pilot Study Comparing Effects of Xanomeline Alone to Xanomeline Plus Trospium
|
Phase 1 | |
Completed |
NCT05517460 -
The Efficacy of Auricular Acupressure on Improving Constipation Among Residents in Community Rehabilitation Center
|
N/A | |
Completed |
NCT03652974 -
Disturbance of Plasma Cytokine Parameters in Clozapine-Resistant Treatment-Refractory Schizophrenia (CTRS) and Their Association With Combination Therapy
|
Phase 4 | |
Recruiting |
NCT04012684 -
rTMS on Mismatch Negativity of Schizophrenia
|
N/A | |
Recruiting |
NCT04481217 -
Cognitive Factors Mediating the Relationship Between Childhood Trauma and Auditory Hallucinations in Schizophrenia
|
N/A | |
Completed |
NCT00212784 -
Efficacy and Safety of Asenapine Using an Active Control in Subjects With Schizophrenia or Schizoaffective Disorder (25517)(P05935)
|
Phase 3 | |
Completed |
NCT04092686 -
A Clinical Trial That Will Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophrenia
|
Phase 3 | |
Completed |
NCT01914393 -
Pediatric Open-Label Extension Study
|
Phase 3 | |
Recruiting |
NCT03790345 -
Vitamin B6 and B12 in the Treatment of Movement Disorders Induced by Antipsychotics
|
Phase 2/Phase 3 | |
Recruiting |
NCT05956327 -
Insight Into Hippocampal Neuroplasticity in Schizophrenia by Investigating Molecular Pathways During Physical Training
|
N/A | |
Terminated |
NCT03261817 -
A Controlled Study With Remote Web-based Adapted Physical Activity (e-APA) in Psychotic Disorders
|
N/A | |
Terminated |
NCT03209778 -
Involuntary Memories Investigation in Schizophrenia
|
N/A | |
Completed |
NCT02905604 -
Magnetic Stimulation of the Brain in Schizophrenia or Depression
|
N/A | |
Recruiting |
NCT05542212 -
Intra-cortical Inhibition and Cognitive Deficits in Schizophrenia
|
N/A | |
Completed |
NCT04411979 -
Effects of 12 Weeks Walking on Cognitive Function in Schizophrenia
|
N/A | |
Terminated |
NCT03220438 -
TMS Enhancement of Visual Plasticity in Schizophrenia
|
N/A |